NCT01737424View on ClinicalTrials.gov

Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

89

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Healthy

Interventions

DRUG

LC28-0126

LC28-0126

DRUG

Placebo

Placebo

Trial Locations (1)

110-744

Seoul National University Hospital, Clinical Trial Center, Seoul

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY

NCT01737424 - Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter